4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-20-053276
Options or other derivatives
- Director acquired 9,247 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ros Matthew Director | 2020-10-01 | Grant or award · Stock Option (Right to Buy) | +9,247 | $1.35 | $12,500 | 9,247 | D |
Loading xslF345X03/doc4.xml…